All News

RGT-075 from Regor Therapeutics demonstrated a statistically significant 5% placebo-adjusted weight loss in adult patients with obesity or overweight.

The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.

Ahead of its first general meeting in 2025, lawmakers called on the FTC to vote “yes” on releasing a second interim staff report on PBMs.

A conversation with Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM.

A combination of ibuprofen and acetaminophen was found to be superior to hydrocodone and acetaminophen in managing pain after impacted mandibular third-molar extraction surgery.

Rite Aid recently released a survey detailing US patients’ perspective of how they engage with their pharmacists.

Sarah Gray, PharmD, GAICD, discussed her experience as a pharmacist who added nutrition counseling to her clinical expertise.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.

To celebrate National Pharmacists Day on January 12, Drug Topics gathered its pharmacist interviews from the past year, exploring expert industry insights in a variety of topics.

Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM, discuss a recent study that examined how wearing a continuous glucose monitor impacts student pharmacists.

Sarah Gray, PharmD, GAICD, known as the Nutrition Pharmacist, joined Drug Topics to discuss her experience with patients looking to begin healthier lifestyles at the start of a new year.

Researchers performed a systematic literature review of the efficacy of amitriptyline for treating patients with irritable bowel syndrome.

Investigators of a recent study said targeted interventions are needed to reduce the global burden, particularly in developing countries.

Researchers conducted a literature research review to further understand the current evidence regarding diagnosis and treatment for peptic ulcer disease.

Henry Ukachukwu Michael, PhD, discusses the importance of optimizing medication utilization in patients with long COVID.

MET-097i from Metsera demonstrated substantial reductions in mean body weight in patients with obesity or overweight who did not have type 2 diabetes.

Patients who receive either Pfizer or GSK’s respiratory syncytial virus vaccine may be at increased risk of Guillain-Barré syndrome.

Six months after the announcement of McKesson Amplify in June, the initiative has secured funding across all 50 states in the US.

Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.

The individual who first reported severe bird flu and hospitalization has since succumbed to their illness.

David Nau, PhD, discusses how more graduating pharmacy students say they would choose pharmacy again if starting college over.

Researchers compared simultaneous and sequential administration of the mRNA COVID-19 and inactivated influenza vaccines.

Rebecca Lahrman, PharmD, MS, BCACP, discusses her experience taking medical students for rotations in a community pharmacy.

US News & World Report nutrition experts detailed the best types of diets for maintaining patient health in 2025.

A study found that of 110 patients with long COVID, over half reported decreased QOL due to pain, discomfort, anxiety, or depression.

PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models

Using the DASH Rapid PCR System, providers can yield test results in under 1 minute of hands-on time.

A study found that sending a letter to providers about standards of care and glucagon preparations could increase glucagon prescription rates.

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Researchers aimed to identify the barriers impeding HPV vaccine uptake since 2019 among US mid-adults aged 27 to 45.